Page 13 - 2020年8月第3期总39期_Neat
P. 13

振东产品           SOCIAL FOCUSPRODUCTS                                   振东学术·ZHENDONG SCIENCE
                社会焦点 ZHENDONG





                                        灯盏花素对老年脑卒中病人血清
                                        灯盏花素对老年脑卒中病人血清
                                       hs-CRP
                                       hs-CRP、、TNF-TNF-αα水平及预后的影响水平及预后的影响
                                                   田   蕾,施春美,张义发
              【摘要】目的:探讨灯盏花素对老年脑卒中病人血清超敏-C反应蛋白(hs-CRP)、肿瘤坏死因子-α(TNF-α)
               水平及预后的影响。方法:将76例老年脑卒中病人随机分为对照组和研究组,各38例。对照组采用常规西

               药治疗,研究组在对照组基础上采用灯盏花素治疗。采用乳胶免疫增强透射比浊法(LETIA)测定血清hs-
               CRP水平,采用酶联免疫吸附试验(ELISA)测定血清TNF-α水平。观察并比较两组临床疗效、血清hs-CRP
               及TNF-α水平美国国立卫生研究院脑卒中量表(NIHSS)、急性生理和慢性健康状况评价系统Ⅱ(APACHE
               Ⅱ)评分、格拉斯哥昏迷评分量表(GCS)变化及不良反应发生情况。结果:研究组总有效率(94.74%)高于对
               照组(65.79%),差异有统计学意义(P<0.05)。治疗后两组血清hs-CRP、TNF-α较治疗前降低(P<0.05),且

               研究组低于对照组(P<0.05);治疗后两组 NIHSS、APACHEⅡ评分低于治疗前,GCS 评分高于治疗前
              (P<0.05),且研究组NIHSS、APACHEⅡ评分低于对照组,GCS评分高于对照组(P<0.05)。研究组药物不良
               反应发生率为 5.26%,低于对照组的 21.05%,差异有统计学意义(P<0.05)。结论:灯盏花素治疗老年脑卒
               中,可降低病人血清hs-CRP、TNF-α水平,进而改善预后。
              【关键词】脑卒中;老年人;灯盏花素;超敏-C反应蛋白;肿瘤坏死因子-α;美国国立卫生研究院脑卒中量

               表;急性生理和慢性健康状况评价系统Ⅱ;格拉斯哥昏迷评分量表
              【中图分类号】R743 R255.2                 【文献标识码】A





                                           Effect of Breviscapine on Serum hs-CRP,of Breviscapine on Serum hs-CRP,
                                           Effect
                                     TNF-αα Levels and Prognosis of Elderly Stroke PatientsLevels and Prognosis of Elderly Stroke Patients
                                     TNF-
                                                Tian Lei, Shi Chunmei, Zhang Yifa
               [Abstract]
               [Abstract] Objective:Objective: To investigate the effect of breviscapine on serum levels of high sensitivity-C reactive protein
               (hs-CRP),tumor necrosis factor-α (TNF-α) and prognosis in elderly stroke patients.MethodsMethods:76 elderly stroke pa-
               tients were randomly divided into control group and study group,38 cases in each group.The control group was treat-
               ed with conventional western medicine,while the study group was treated with breviscapine based on the control
               group.The serum hs-CRP level was determined by latex immunoenhancement turbidimetry(LETIA) and the serum
               TNF- α level was determined by enzyme linked immunosorbent assay (ELISA).The clinical efficacy,serum hs-

               CRP and TNF - α levels of the two groups were observed and compared. The changes of NIHSS, APACHE II,
               Glasgow Coma Scale (GCS) and adverse reactions were observed and compared.ResultsResults:The total effective rate of
               the study group (94.74%) was higher than that of the control group (65.79%),with statistically significant differ-
               ence (P<0.05).After treatment,the serum hs-CRP and TNF-α of the two groups were lower than before treatment

               (P<0.05),and the study group was lower than the control group (P<0.05).After treatment,the NIHSS and APACHEⅡ
               scores of the two groups were lower than before treatment,and GCS scores were higher than before treatment (P<0.05).


                                                                                           丝缕求细 点滴求精        08
   8   9   10   11   12   13   14   15   16   17   18